Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD)

NCT01483053 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder (MDD)

Interventions

DRUG: Agomelatine
DRUG: Escitalopram

Sponsor

Baker Heart and Diabetes Institute

Collaborators

[object Object]
[object Object]
[object Object]